Summary & Overview
CPT 83525: Total Insulin Measurement, Serum
CPT code 83525 represents a quantitative laboratory assay measuring total insulin in serum, reporting both protein-bound and free insulin. This laboratory test is clinically relevant for evaluating insulin production, monitoring metabolic and endocrine disorders, and informing diagnostic workups for hypoglycemia, hyperinsulinemia, and related metabolic conditions. As a widely ordered endocrine lab test, it has implications for clinical management and billing across outpatient and hospital laboratory settings nationwide.
Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage and billing considerations across major payers, typical sites of service for performance of the assay, and relevant clinical context for test utilization. The summary highlights common modifiers used with laboratory services and notes where input data is limited.
This publication provides benchmarks for utilization and reimbursement patterns, outlines coding and billing nuances for CPT code 83525, and summarizes clinical indications that commonly prompt ordering of a total insulin assay. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 83525 describes a laboratory measurement of total insulin in a serum sample. The test quantifies both protein-bound insulin and free insulin circulating in the blood to assess overall insulin levels.
Service type: Laboratory diagnostic service — quantitative hormone assay
Typical site of service: Clinical laboratory or hospital outpatient laboratory
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45-year-old adult presenting to an outpatient laboratory or hospital clinical laboratory for evaluation of suspected insulin dysregulation. Common scenarios include assessment of endogenous insulin levels in patients with hypoglycemia of unclear etiology, evaluation of hyperinsulinemia in suspected insulinoma, or monitoring insulin production in metabolic research or endocrine workups. The clinician (endocrinologist, primary care physician, or emergency physician) orders a serum total insulin measurement (83525).
Workflow: The patient undergoes venipuncture at a phlebotomy station in an outpatient lab, hospital lab, or emergency department. A serum specimen is collected, processed (centrifuged) per laboratory protocol, and sent to the clinical chemistry laboratory. A lab technologist or automated analyzer performs the total insulin assay, producing a quantitative result that is reported to the ordering provider and entered into the electronic medical record. Results are used alongside glucose measurements, C-peptide, and clinical findings to guide diagnostic or treatment decisions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation component if applicable to an external lab consultation. |